GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curacle Co Ltd (XKRX:365270) » Definitions » EV-to-EBITDA

Curacle Co (XKRX:365270) EV-to-EBITDA : -4.28 (As of Jun. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Curacle Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Curacle Co's enterprise value is ₩55,317 Mil. Curacle Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-12,937 Mil. Therefore, Curacle Co's EV-to-EBITDA for today is -4.28.

The historical rank and industry rank for Curacle Co's EV-to-EBITDA or its related term are showing as below:

XKRX:365270' s EV-to-EBITDA Range Over the Past 10 Years
Min: -59.53   Med: -13.75   Max: -4.27
Current: -4.27

During the past 7 years, the highest EV-to-EBITDA of Curacle Co was -4.27. The lowest was -59.53. And the median was -13.75.

XKRX:365270's EV-to-EBITDA is ranked worse than
100% of 493 companies
in the Biotechnology industry
Industry Median: 8.54 vs XKRX:365270: -4.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-03), Curacle Co's stock price is ₩4480.00. Curacle Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1160.000. Therefore, Curacle Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Curacle Co EV-to-EBITDA Historical Data

The historical data trend for Curacle Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curacle Co EV-to-EBITDA Chart

Curacle Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial - -43.43 -12.61 -14.46 -6.25

Curacle Co Quarterly Data
Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.69 -4.75 -4.84 -6.25 -6.57

Competitive Comparison of Curacle Co's EV-to-EBITDA

For the Biotechnology subindustry, Curacle Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curacle Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curacle Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curacle Co's EV-to-EBITDA falls into.


;
;

Curacle Co EV-to-EBITDA Calculation

Curacle Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=55317.469/-12937.356
=-4.28

Curacle Co's current Enterprise Value is ₩55,317 Mil.
Curacle Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-12,937 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curacle Co  (XKRX:365270) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Curacle Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4480.00/-1160.000
=At Loss

Curacle Co's share price for today is ₩4480.00.
Curacle Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1160.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Curacle Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curacle Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Curacle Co Business Description

Traded in Other Exchanges
N/A
Address
54, Changeop-ro, Sujeong-gu, Ga dong, No. 608~611, Business growth support center, Sujeong-gu, Gyeonggi-do, Seongnam-si, KOR, 608~611
Curacle Co Ltd is engaged in developing innovative new drugs with creative technology for incurable diseases caused by the aging process and damage to blood vessels.

Curacle Co Headlines

No Headlines